Ancient dao-yin exercise may ease chemotherapy side effects in breast cancer patients
NCT ID NCT07262099
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a traditional Daoist exercise called Shangshou Dao-yin could improve sleep, body constitution, and quality of life in breast cancer patients undergoing chemotherapy. 150 women who had surgery for breast cancer and were starting chemotherapy were assigned to either practice the exercise daily for 20 minutes or receive standard care. The results may show whether this gentle, equipment-free exercise helps reduce sleep problems and enhance well-being during cancer treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Shangshou Dao-yin (a traditional Daoist mind-body exercise with gentle movements and breathing)
- What this could lead to
- If it works, this could offer a simple, equipment-free way to help breast cancer patients feel better during chemotherapy, with better sleep and quality of life.
- What could go wrong
- This is a small, completed study where patients chose their group, not a randomized trial, so results may be less reliable. The exercise may not work for everyone, and benefits might be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
150 people
The number who actually took part.
- Started
-
Jan 2017
- Finished
-
Nov 2019
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 99 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Newly diagnosed Stage I, II, or III breast cancer with surgical tumor removal followed by adjuvant chemotherapy. 2. Age ≥ 20 years. 3. Ability to walk independently without movement restrictions. 4. Able to communicate in Mandarin or Taiwanese. 5. Provided written informed consent. Exclusion Criteria: 1. Regularly practicing Tai Chi or other mind-body exercises at the time of enrollment. 2. Pre-existing chronic illnesses or symptoms that may interfere with evaluation of chemotherapy-related side effects (e.g., chronic diarrhea, neuropathy, heart failure, thromboembolic disease, chronic pulmonary or renal disease, alopecia). 3. Pregnancy. 4. Severe psychiatric illness (e.g., schizophrenia, major depressive disorder).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tri-Service General Hospital
Taipei, Taipei City, 11490, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a faster radiation course match the standard one after breast reconstruction?
- Can High-Risk breast cancer patients skip an extra radiation boost?
- Radioactive probe lights up CD73 on breast tumors in PET scans
- Can time with horses help cancer patients feel better?
- Can an oral drug replace injections for advanced breast cancer?
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?